
    
      This is an observational study to monitor the treatment of donor-specific antibodies in lung
      transplant recipients with detection of donor-specific antibodies. All consented subjects
      will be approached for participation. The study will evaluate the effectiveness of the
      treatment protocol of donor-specific antibodies with Immunoglobulins or combined treatment
      with Immunoglobulins, Plasmapheresis and Rituximab after lung transplantation.
    
  